Metraipolis › archive › dc_466e01c243fa

Biologic therapy in geriatric psoriasis: 6-month real-world data on PASI, inflammatory indices, and hepatitis B/tuberculosis safety — Europe PMC PMID:41778961

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41778961
DOI: 10.17305/bb.2026.13927
License (as archived): solo-consultazione
Archived: 2026-11-05T03:44:07.138Z
SHA-256 of the archived text: 0d0360e02b823eff08d47e9c1ae49137efff11e18816c9f31e2f32c10501183d
Stable URL of this page: https://metraipolis.com/documento/dc_466e01c243fa

How to cite

Biologic therapy in geriatric psoriasis: 6-month real-world data on PASI, inflammatory indices, and hepatitis B/tuberculosis safety — Europe PMC PMID:41778961 — Europe PMC (en), https://europepmc.org/article/MED/41778961 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_466e01c243fa (Metraipolis archive dc_466e01c243fa, sha256 0d0360e02b823eff08d47e9c1ae49137efff11e18816c9f31e2f32c10501183d)

BibTeX

@misc{dc466e01c243fa,
  title = {Biologic therapy in geriatric psoriasis: 6-month real-world data on PASI, inflammatory indices, and hepatitis B/tuberculosis safety — Europe PMC PMID:41778961},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41778961},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_466e01c243fa; sha256 0d0360e02b823eff08d47e9c1ae49137efff11e18816c9f31e2f32c10501183d},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41778961. Agents can read the archived copy with the MCP tool read_document.